评估乳腺X线筛查有效性:国际癌症研究机构2015年建议需要修订
该观点文章指出,观察性研究显示参加乳腺X线筛查者较从不参加者乳腺癌死亡风险降低45%(95%CI:40-50%)、非乳腺癌死亡风险降低46%(95%CI:42-50%),提示参加筛查可能反映与更低全因死亡风险相关的个人特征,观察性研究可能将这种特征误读为筛查效果。文章质疑国际癌症研究机构2015年建议,主张恢复其2002年基于描述性和比较性研究的建议。
要点
- 观察性研究中参加筛查者乳腺癌死亡风险降低45%、非乳腺癌死亡风险降低46%,后者提示选择偏倚。
- 乳腺X线筛查对非乳腺癌死亡原因无已知有益影响,乳腺癌死亡风险降低幅度应大于全因死亡风险降低幅度。
- 文章质疑国际癌症研究机构2015年建议,主张恢复其2002年基于描述性和比较性研究的建议。
核心结论
- 观察性研究显示的乳腺X线筛查与乳腺癌死亡风险降低的关联可能被个人特征(自选择偏倚)混淆,文章质疑国际癌症研究机构2015年建议并主张恢复其2002年建议。
研究设计与样本
- 观点文章,基于对观察性研究(队列和病例对照)的系统综述;国际癌症研究机构2015年观点认为观察性研究是评估乳腺X线筛查有效性的首选方法,并认为可采用统计方法校正参加与不参加筛查女性之间的个人特征差异(自选择偏倚)。
诊断标准与关键数值
- 与从不参加筛查的女性相比,参加筛查者乳腺癌死亡风险降低45%(95%CI:40-50%)。
- 与从不参加筛查的女性相比,参加筛查者非乳腺癌死亡风险降低46%(95%CI:42-50%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast cancer screening effectiveness is measured by its ability to reduce breast cancer mortality in real world settings. A viewpoint issued by the International Agency for Research on Cancer (IARC) in 2015 considered that observational studies (cohort and case-control) are the preferred methods to evaluate the effectiveness of mammography screening. A statistical method was deemed to correct for differences in personal characteristics between women choosing to attend or to not attend screening (self-selection bias). But we showed in a systematic review of observational studies that, compared to women who never attend screening, attenders have a 45 % reduction in their risk of breast cancer death (95 % CI: 40-50 %) and a 46 % reduction (95 % CI: 42-50 %) in their risk of death from a cause other than breast cancer. Screening mammography has no known beneficial influence on causes of death other than breast cancer. If screening mammography reduced the risk of breast cancer death, one would expect a much greater percentage reduction in the risk of breast cancer death than in the risk of all-cause death. Our results suggest that screening mammography attendance is an indicator of personal characteristics associated with a lower risk of dying from any cause, including from breast cancer, which observational studies have misinterpreted as a screening effect. This paper calls into question the IARC 2015 recommendations and advocates the reinstatement of recommendations made by the IARC in 2002 which were based on the use of descriptive and comparative studies.
引用
- Autier P, Jørgensen KJ, Støvring H, et al. Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision. Eur J Cancer. 2025. PMID: 40712255. doi:10.1016/j.ejca.2025.115657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。